[HTML][HTML] Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma
WA Hassan, AK ElBanna, N Noufal… - … of Pathology and …, 2023 - synapse.koreamed.org
Background Tumor-infiltrating neutrophils and lymphocytes play essential roles in promoting
or combating various neoplasms. This study aimed to investigate the association between …
or combating various neoplasms. This study aimed to investigate the association between …
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?
G Mantica, F Chierigo, R Malinaric, S Smelzo… - Medicina, 2022 - mdpi.com
Background and Objectives: To evaluate the oncological impact of squamous cell carcinoma
(SCC) variant in patients submitted to intravesical therapy for non-muscle-invasive bladder …
(SCC) variant in patients submitted to intravesical therapy for non-muscle-invasive bladder …
[HTML][HTML] The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
KWA Khattab, NS Alazzo… - Medical Journal of …, 2024 - journals.lww.com
Background: Urothelial carcinoma (UC) has been considered the most frequent bladder
tumor. Although the degree of bladder wall invasion and grade of the tumor are the essential …
tumor. Although the degree of bladder wall invasion and grade of the tumor are the essential …
Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC)
NF Elaidy, AM Abdelbary, ER Qasem… - The Egyptian Journal …, 2023 - journals.ekb.eg
Background: Though linked with a favorable overall survival rate, the heterogeneity of
NMIBC (non-muscle invasive bladder cancer) has an effect on patients' rates of recurrence …
NMIBC (non-muscle invasive bladder cancer) has an effect on patients' rates of recurrence …
[PDF][PDF] HER2 Overexpression In Urothelial Carcinoma Is Closely Associated With Disease Progression: A Single-Center Retrospective Study
Q Li, X Su, W Xu, L Qing, Y Yang, H Wang, S Chen… - 2022 - scholar.archive.org
Background: Urothelial carcinoma especially metastatic UC, is still challenging to treat and
associated poor outcomes remain. It is urgent to nd new targets to change the treatment …
associated poor outcomes remain. It is urgent to nd new targets to change the treatment …